Endothelium-derived hydrogen peroxide accounts for the improved EDHF-mediated relaxations caused by long-term treatment with an angiotensin converting enzyme inhibitor in mice

被引：0
|
作者：
Fujiki, T [1 ]
Kubota, H [1 ]
Morikawa, K [1 ]
Matoba, T [1 ]
Talukder, MAH [1 ]
Hatanaka, M [1 ]
Shimokawa, H [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Japan
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
907
引用
收藏
页码：192 / 192
页数：1
相关论文
共 28 条
  • [1] Endothelium-derived hydrogen peroxide accounts for the enhanced EDHF-mediated relaxations by long-term treatment with an angiotensin converting enzyme inhibitor in mice
    Fujiki, T
    Kubota, H
    Hatanaka, M
    Morikawa, K
    Talukder, MAH
    Matoba, T
    Shimokawa, H
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 11 (01): : 73 - 73
  • [2] Endothelium-derived hydrogen peroxide accounts for the enhanced EDHF-mediated relaxation by long-term treatment with an angiotensin-converting enzyme inhibitor in mice
    Fujiki, T
    Hatanaka, M
    Morikawa, K
    Kubota, H
    Matoba, T
    Talukder, MAH
    Shimokawa, H
    CIRCULATION, 2004, 110 (17) : 77 - 77
  • [3] Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensin-converting enzyme inhibitor on endothelium-derived hyperpolarizing factor-mediated responses in mice
    Fujiki, T
    Shimokawa, H
    Morikawa, K
    Kubota, H
    Hatanaka, M
    Talukder, MAH
    Matoba, T
    Takeshita, A
    Sunagawa, K
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (04) : 766 - 771
  • [4] Endothelium-derived hydrogen peroxide accounts for the enhancing effect of an angiotensin-converting enzyme inhibitor on endothelium-derived hyperpolarizing factor-mediated responses in mice
    Fujiki, T
    Morikawa, K
    Kubota, H
    Hatanaka, M
    Talukder, MAH
    Matoba, T
    Shimokawa, H
    JOURNAL OF VASCULAR RESEARCH, 2005, 42 : 64 - 64
  • [5] LONG-TERM TREATMENT OF HYPERTENSION BY AN INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME
    WAEBER, B
    GAVRAS, H
    BRUNNER, HR
    CHAPPUIS, P
    TURINI, GA
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1978, 108 (49) : 1981 - 1983
  • [6] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS
    BRUNNER, HR
    GAVRAS, H
    WAEBER, B
    KERSHAW, GR
    TURINI, GA
    VUKOVICH, RA
    MCKINSTRY, DN
    GAVRAS, I
    ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) : 19 - 23
  • [7] LONG-TERM ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR TREATMENT DOES NOT AFFECT SERUM PROLACTIN
    POOL, JL
    NELSON, EB
    CASAR, G
    BOYD, AE
    CLINICAL RESEARCH, 1987, 35 (03): : A400 - A400
  • [8] LONG-TERM TREATMENT OF CHRONIC CARDIAC-FAILURE BY AN ANGIOTENSIN CONVERTING ENZYME-INHIBITOR
    KOMAJDA, M
    EUGENE, M
    EVANS, J
    LAURENCEAU, JL
    HUBERMAN, JB
    THOMAS, D
    DROBINSKI, G
    LEPRINCE, JL
    GANTY, J
    WAJMAN, A
    GUEDJ, D
    GROSGOGEAT, Y
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1983, 76 (01): : 29 - 36
  • [9] LONG-TERM TREATMENT WITH QUINAPRIL, AN ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, OF CHRONIC AORTIC AND MITRAL REGURGITATION
    SCHON, HR
    SCHOMIG, A
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1995, 120 (13) : 429 - 435
  • [10] LONG-TERM TREATMENT OF HYPERTENSION IN MAN BY AN ORALLY ACTIVE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    BRUNNER, HR
    GAVRAS, H
    TURINI, GA
    WAEBER, B
    CHAPPUIS, P
    MCKINSTRY, DN
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 55 : S293 - S295
123